Literature DB >> 23277402

Role of DNA repair and cell cycle control genes in ovarian cancer susceptibility.

Faten Zahran Mohamed1, Yousry Mostafa Hussien, Mohamad Mohamad AlBakry, Randa H Mohamed, Noha Mohamed Said.   

Abstract

Recent studies have identified several single nucleotide polymorphisms (SNPs) in the population that are associated with variations in the risks of many different cancer diseases. For ovarian cancer, the known highly penetrant susceptibility genes (BRCA1 and BRCA2) are probably responsible for only 40% of the excess familial ovarian cancer risks, suggesting that other susceptibility genes of lower penetrance exist. The aim of the present study was to evaluate the role of SNPs in three genes, XRCC2 (R188H), ERCC2 (K751Q) and CDKN1B (V109G) which are with moderate risk for ovarian cancer susceptibility in Egyptian women. We further investigated the potential combined effect of these genes variants on ovarian cancer risk. The three genes polymorphisms were characterized in 100 ovarian cancer Egyptian females and 100 healthy women by (RFLP-PCR) method in a case control study. Our results revealed that the frequencies of AC genotypes of ERCC2 (K751Q), and GG genotypes of CDKN1B (V109G) polymorphisms were significantly higher in EOC patients than in normal individual (P = 0.007, 0.02 respectively). The frequencies of AA genotype of XRCC2 (R188H) and CC genotype of ERCC2 (K751Q) were higher in EOC patients than in normal individual but without significance (P = 0.06, 0.38 respectively). Also, no association between any one of the three studied genes polymorphisms and the clinical characteristics of disease. The combination of GA (XRCC2) + AC (ERCC2) + GG (CDKN1B) was significantly associated with increased EOC risk. Also, the combination for GA (XRCC2) + AC (ERCC2) and the combination of AA (XRCC2) + CC (ERCC2) were significantly associated with increased EOC risk. There was significant difference in CA125 values between EOC and control Group (P < 0.001). Our results suggested that, XRCC2, ERCC2 and CDKN1B genes are important candidate genes for susceptibility to EOC. Also, gene-gene interaction between GA (XRCC2) + AC (ERCC2) + GG (CDKN1B) polymorphism may be associated with increased risk of EOCC in Egyptian women.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23277402     DOI: 10.1007/s11033-012-2452-8

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  31 in total

Review 1.  Control of the cell cycle and apoptosis.

Authors:  A S Lundberg; R A Weinberg
Journal:  Eur J Cancer       Date:  1999-12       Impact factor: 9.162

2.  Importance of xeroderma pigmentosum group D polymorphisms in susceptibility to ovarian cancer.

Authors:  Sandra Costa; Daniela Pinto; Deolinda Pereira; André Vasconcelos; Carlos Afonso-Lopes; Teresa Osório; Carlos Lopes; Rui Medeiros
Journal:  Cancer Lett       Date:  2006-05-04       Impact factor: 8.679

3.  ERCC2 genotypes and a corresponding haplotype are linked with breast cancer risk in a German population.

Authors:  Christina Justenhoven; Ute Hamann; Beate Pesch; Volker Harth; Sylvia Rabstein; Christian Baisch; Caren Vollmert; Thomas Illig; Yon-Dschun Ko; Thomas Brüning; Hiltrud Brauch
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2004-12       Impact factor: 4.254

4.  XPD common variants and their association with melanoma and breast cancer risk.

Authors:  T Debniak; R J Scott; T Huzarski; T Byrski; B Masojć; T van de Wetering; P Serrano-Fernandez; B Górski; C Cybulski; J Gronwald; B Debniak; R Maleszka; J Kładny; A Bieniek; L Nagay; O Haus; E Grzybowska; P Wandzel; S Niepsuj; S A Narod; J Lubinski
Journal:  Breast Cancer Res Treat       Date:  2006-05-10       Impact factor: 4.872

Review 5.  Risk prediction models for familial breast cancer.

Authors:  Antonis C Antoniou; Douglas F Easton
Journal:  Future Oncol       Date:  2006-04       Impact factor: 3.404

6.  Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland.

Authors:  P Lichtenstein; N V Holm; P K Verkasalo; A Iliadou; J Kaprio; M Koskenvuo; E Pukkala; A Skytthe; K Hemminki
Journal:  N Engl J Med       Date:  2000-07-13       Impact factor: 91.245

7.  Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium.

Authors:  D Ford; D F Easton; M Stratton; S Narod; D Goldgar; P Devilee; D T Bishop; B Weber; G Lenoir; J Chang-Claude; H Sobol; M D Teare; J Struewing; A Arason; S Scherneck; J Peto; T R Rebbeck; P Tonin; S Neuhausen; R Barkardottir; J Eyfjord; H Lynch; B A Ponder; S A Gayther; M Zelada-Hedman
Journal:  Am J Hum Genet       Date:  1998-03       Impact factor: 11.025

8.  [Single nucleotide polymorphisms in cell cycle regulator p21 and p27 genes are associated with susceptibility to epithelial ovarian cancer].

Authors:  Xia Jin; Shan Kang; Na Wang; Yan-Ping Xing; Yan Li
Journal:  Zhonghua Fu Chan Ke Za Zhi       Date:  2008-03

Review 9.  Role of genetic polymorphisms and ovarian cancer susceptibility.

Authors:  Peter A Fasching; Simon Gayther; Leigh Pearce; Joellen M Schildkraut; Ellen Goode; Falk Thiel; Georgia Chenevix-Trench; Jenny Chang-Claude; Shan Wang-Gohrke; Susan Ramus; Paul Pharoah; Andrew Berchuck
Journal:  Mol Oncol       Date:  2009-02-04       Impact factor: 6.603

10.  STK15 polymorphisms and association with risk of invasive ovarian cancer.

Authors:  Richard A Dicioccio; Honglin Song; Christy Waterfall; Makoto T Kimura; Hiroki Nagase; Valerie McGuire; Estrid Hogdall; Mitul N Shah; Robert N Luben; Douglas F Easton; Ian J Jacobs; Bruce A J Ponder; Alice S Whittemore; Simon A Gayther; Paul D P Pharoah; Susan Kruger-Kjaer
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2004-10       Impact factor: 4.254

View more
  10 in total

1.  Association of reduced XRCC2 expression with lymph node metastasis in breast cancer tissues.

Authors:  Nabiha Bashir; Syeda Sana; Ishrat Mahjabeen; Mahmood Akhtar Kayani
Journal:  Fam Cancer       Date:  2014-12       Impact factor: 2.375

2.  The effect of RAD51 135 G>C and XRCC2 G>A (rs3218536) polymorphisms on ovarian cancer risk among Caucasians: a meta-analysis.

Authors:  Shujing Shi; Lingyan Qin; Mengqiu Tian; Mao Xie; Xiaoxue Li; Chenglin Qi; Xiang Yi
Journal:  Tumour Biol       Date:  2014-03-06

3.  An association between the -41657 C/T polymorphism of X-ray repair cross-complementing 2 (XRCC2) gene and ovarian cancer.

Authors:  Magdalena M Michalska; Dariusz Samulak; Beata Smolarz
Journal:  Med Oncol       Date:  2014-10-30       Impact factor: 3.064

4.  Germline CDKN1B Loss-of-Function Variants Cause Pediatric Cushing's Disease With or Without an MEN4 Phenotype.

Authors:  Fanny Chasseloup; Nathan Pankratz; John Lane; Fabio R Faucz; Margaret F Keil; Prashant Chittiboina; Denise M Kay; Tara Hussein Tayeb; Constantine A Stratakis; James L Mills; Laura C Hernández-Ramírez
Journal:  J Clin Endocrinol Metab       Date:  2020-06-01       Impact factor: 5.958

5.  Association of XRCC2 rs3218536 Polymorphism with Susceptibility of Breast and Ovarian Cancer: A Systematic Review and Meta-Analysis

Authors:  Mahdieh Kamali; Sedigheh Hamadani; Hossein Neamatzadeh; Mahta Mazaheri; Masoud Zare Shehneh; Mitra Modaress Gilani; Fatemeh Haghighi
Journal:  Asian Pac J Cancer Prev       Date:  2017-07-27

Review 6.  Associations between XRCC2 rs3218536 and ERCC2 rs13181 polymorphisms and ovarian cancer.

Authors:  Wei Zhang; Zhifen Zhang
Journal:  Oncotarget       Date:  2016-12-27

7.  p27-V109G Polymorphism Is Not Associated with the Risk of Prostate Cancer: A Case-Control Study of Han Chinese Men in Central China.

Authors:  Meng Zhang; Qianjun Liang; Ligang Zhang; Zongyao Hao; Jun Zhou; Li Zhang; Song Fan; Chaozhao Liang
Journal:  Dis Markers       Date:  2018-03-20       Impact factor: 3.434

8.  Cell-cycle synchronization reverses Taxol resistance of human ovarian cancer cell lines.

Authors:  Xueqing Wang; Lingya Pan; Ning Mao; Lifang Sun; Xiangjuan Qin; Jie Yin
Journal:  Cancer Cell Int       Date:  2013-07-30       Impact factor: 5.722

9.  Analysis of the association between the XRCC2 rs3218536 polymorphism and ovarian cancer risk.

Authors:  Cunzhong Yuan; Xiaoyan Liu; Rongrong Li; Shi Yan; Beihua Kong
Journal:  Arch Med Sci       Date:  2020-04-25       Impact factor: 3.318

Review 10.  Genetic Association Between CDKN1B rs2066827 Polymorphism and Susceptibility to Cancer.

Authors:  Yongchao Lu; Kejian Gao; Miao Zhang; Aiyan Zhou; Xiaoming Zhou; Zhongan Guan; Xuewen Shi; Shujian Ge
Journal:  Medicine (Baltimore)       Date:  2015-11       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.